title: Rapamycin treatment at immunosuppressive doses affects tumor blood vessel circulation.
authors.affiliation: Department of Surgery, University of Regensburg, Regensburg, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Koehl
authors.forename: M
authors.initials: M
authors.lastname: Guba
authors.forename: H
authors.initials: H
authors.lastname: Seeliger
authors.forename: M
authors.initials: M
authors.lastname: Steinbauer
authors.forename: M
authors.initials: M
authors.lastname: Anthuber
authors.forename: K-W
authors.initials: KW
authors.lastname: Jauch
authors.forename: E K
authors.initials: EK
authors.lastname: Geissler
mesh_terms: D000230:Adenocarcinoma / Q000098:blood supply / Q000188:drug therapy; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000098:blood supply* / Q000188:drug therapy*; D004195:Disease Models, Animal; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D020123:Sirolimus / Q000627:therapeutic use*
chemical_list: D020533:Angiogenesis Inhibitors; D000903:Antibiotics, Antineoplastic; D007166:Immunosuppressive Agents; D020123:Sirolimus